Previous reports have suggested that activation of androgen/AR signaling has a positive effect on the initiation and progression of various cancer cells, including prostate cancer, renal cell carcinoma [27], bladder cancer [28], and hepatocellular carcinoma [29]. The gene discussed is AR; the disease is urinary bladder cancer.